Clinical Trials in Cleveland

Showing 7341-7360 of 19,775 trials

Study Using Negative Pressure to Reduce Apnea

NCT04861038

The objective of this study is to determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive Sleep Apnea (OSA) over 24 weeks of home use in spontaneously breathing adult subjects who are intolerant of Continuous Positive Airway Pressure (CPAP) therapy.

Sleep Apnea, ObstructiveApnea, Sleep

Sommetrics, Inc.900 participantsStarted Nov 2021

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +12 more locations

COMPLETED< 1 mile

Laser Ablation After Stereotactic Radiosurgery

NCT01651078

The need for new technologies and devices in the field of neurosurgery is well established. In April 2013, FDA cleared NeuroBlate™ System, minimally invasive robotic laser thermotherapy tool. It employs a pulsed surgical laser to deliver targeted energy to abnormal brain tissue caused by tumors and lesions. This post-marketing, multi-center study will include patients with metastatic tumors who failed stereotactic radiosurgery and are already scheduled for NeuroBlate procedure. The study will collect clinical outcome, Quality of Life (QoL) and, where feasible, healthcare utilization data for publication.

Metastatic Brain TumorsProgressionRadiation Necrosis+1 more

Monteris Medical44 participantsStarted Jul 2012

New Haven, Connecticut, United States • Kansas City, Kansas, United States • St Louis, Missouri, United States +4 more locations

Study Using Negative Pressure to Reduce Apnea

Laser Ablation After Stereotactic Radiosurgery

Find Trials by Condition in Cleveland

BI 894999 First in Human Dose Finding Study in Advanced Malignancies

Study to Assess the Efficacy and Safety of Orismilast in Psoriasis

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

iPeer2Peer Program for Youth With Sickle Cell Disease

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors

The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

Financial Incentives, Randomization With Stepped Treatment Trial

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

OPTIMISE-CKD Drug Utilization

Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies